Conference Coverage

ISC: Imaging supplants clocks for targeting stroke reperfusion

View on the News

Imaging makes new stroke assessments possible

Traditionally, we have used a clock to identify patients who are eligible to receive reperfusion therapy, but now researchers are trying to extend patient eligibility with imaging. The Stanford (Calif.) team is trying to identify good candidates for reperfusion treatment who present with acute ischemic strokes beyond the traditional time window of 6 hours. The researchers at Massachusetts General Hospital, Boston, and their collaborators are trying to apply a similar approach to patients who have unwitnessed strokes and so have an unknown elapsed time from the start of their stroke.

The rationale behind the Stanford work is that some patients will have salvageable neurons beyond the traditional treatment time window and that this tissue can be identified by MR and CT perfusion imaging.

Mitchel L. Zoler/Frontline Medical News

Dr. Bruce I. Ovbiagele

The workers in Boston and their collaborators used MR diffusion weighted imaging to confirm that a patient has had a stroke, and then use MR fluid attenuated inversion recovery (FLAIR) to determine if the stroke had occurred within the previous 4 hours. If a stroke has not been going on long enough to produce a positive FLAIR image, it means that the patient is still eligible for thrombolytic therapy. This could be huge for U.S. clinical practice because so many patients have unwitnessed strokes. We definitely need a larger efficacy study, but the results Dr. Schwamm reported are highly encouraging.

CT is more widely available right now in U.S. practice than is MRI, so ideally we would like to be able to use CT imaging.

Dr. Bruce I. Ovbiagele is professor and chairman of neurology at the Medical University of South Carolina in Charleston. He had no disclosures. He made these comments in an interview.


 

AT THE INTERNATIONAL STROKE CONFERENCE

References

Dr. Lee H. Schwamm Mitchel L. Zoler/Frontline Medical News

Dr. Lee H. Schwamm

This phase II study’s primary safety endpoint was the incidence of symptomatic intracerebral hemorrhage following alteplase treatment, which occurred in 1 of the 80 patients (1.25%), not a statistically significant difference when compared with the historical standard, the 2.4% rate seen in stroke patients treated with intravenous alteplase 3 to 4.5 hours after their known stroke onset in the ECASS III (European Cooperative Acute Stroke Study) (N Engl J Med. 2008 Sept 25;359[13]:1317-29). The rate of asymptomatic intracerebral hemorrhage was not significantly different between the new study and ECASS III, reported Dr. Lee H. Schwamm, director of TeleStroke & Acute Stroke Services at the Massachusetts General Hospital in Boston.

Based on this result, “we know this approach is safe, and we saw a signal of efficacy, but we really don’t know how effective it will be” until this approach to assessing unwitnessed-stroke patients by imaging undergoes testing in a phase III trial, cautioned Dr. Schwamm at the meeting, sponsored by the American Heart Association.

Future work will also examine whether similar results can be obtained by CT imaging, which would “open this approach to every U.S. emergency department,” Dr. Schwamm said. Although the MR diffusion-weighted imaging and FLAIR analyses used in the current study do not require anything more than standard MRI equipment and software, it remains less available than CT imaging at most U.S. hospitals, he said.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

What’s next for Watchman stroke prevention device
MDedge Neurology
COPD exacerbation amps up stroke risk
MDedge Neurology
Influenza linked to atrial fibrillation in large observational study
MDedge Neurology
Elevated cardiovascular risks linked to hidradenitis suppurativa
MDedge Neurology
VIDEO: Migraine plus aura doubles ischemic stroke rate
MDedge Neurology
VIDEO: Post-stroke pioglitazone modestly protective against secondary vascular events
MDedge Neurology
VIDEO: Octogenarians benefit from ischemic stroke thrombectomy
MDedge Neurology
VIDEO: Stenting in asymptomatic patients noninferior to endarterectomy at 5 years
MDedge Neurology
ISC: Carotid surgery, stenting offer patients balanced alternatives
MDedge Neurology
VIDEO: Rapidly improving stroke patients still at risk for bad outcomes
MDedge Neurology